Covered recipient · General Payments record
BRANDI NICOLE BURNS
Allopathic & Osteopathic Physicians Pediatrics
General Payments · PY2021–2024
$882.91
- Reported across 51 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $330.01 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $121.13 | 6 |
| SANOFI PASTEUR INC. | $58.19 | 3 |
| GlaxoSmithKline, LLC. | $42.68 | 2 |
| Cranial Technologies, Inc | $34.97 | 2 |
| ALK-Abello, Inc | $25.33 | 1 |
| Seqirus USA Inc | $18.15 | 1 |
| Merck Sharp & Dohme Corporation | $16.01 | 1 |
| Phadia US Inc. | $13.55 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ALK-Abello, Inc | $25.33 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099889411 | CMS |
| Cranial Technologies, Inc | $15.62 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082249250 | CMS |
| Cranial Technologies, Inc | $19.35 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082249252 | CMS |
| GlaxoSmithKline, LLC. | $25.60 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116117117 | CMS |
| GlaxoSmithKline, LLC. | $17.08 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116405769 | CMS |
| Merck Sharp & Dohme LLC | $16.01 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141651633 | CMS |
| PFIZER INC. | $23.46 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131285769 | CMS |
| PFIZER INC. | $17.02 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131375537 | CMS |
| PFIZER INC. | $14.97 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132033657 | CMS |
| PFIZER INC. | $21.15 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131602436 | CMS |
| PFIZER INC. | $24.75 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131939825 | CMS |
| PFIZER INC. | $19.78 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130883726 | CMS |
| Phadia US Inc. | $13.55 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067576354 | CMS |
| SANOFI PASTEUR INC. | $20.47 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128753237 | CMS |
| SANOFI PASTEUR INC. | $18.07 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128753239 | CMS |
| SANOFI PASTEUR INC. | $19.65 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128753243 | CMS |
| Seqirus USA Inc | $18.15 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125630200 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.